Clinical Trial Update: Trial of Methyl Aminolevulinate Plus Aktilite in Facial Photodamage [Phase 3]

View source ↗

Summary

This update reports a Phase 3 trial evaluating methyl aminolevulinate in combination with the Aktilite blue-light device for facial photodamage (photoaging). Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Photoaging

Drugs mentioned

• Aktilite blue light device
• Methyl aminolevulinate (methyl aminolevulinate)

Snippet

Sponsor: Universidad de Antioquia | Conditions: Skin Aging | Phase 3 | Status: COMPLETED